|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.985 USD | -1.49% |
|
-11.95% | -28.25% |
| 06-30 | Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell 2500 Growth Benchmark | CI |
Evolution of the Average Target: Galectin Therapeutics Inc.
Evolution of the Target Price: Galectin Therapeutics Inc.
Changes in Analyst Recommendations: Galectin Therapeutics Inc.
c3b3.I1RCR-kHRudgXF3OgZw6KhBzZ_Usi8b39KRwiU4gwhY.Uxx7Aa1BF940DhmZwMVPTVogFsVg_qChnsYy7CpjnXpTMzsln042sBkSBA~586d54e6f253b1d5e8d0e519d955672e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| - | - | +268.51% | ||||
| +22.34% | ||||||
| +7% | ||||||
| +20.58% | ||||||
| +29.2% | ||||||
| +42.47% | ||||||
| +25.91% | ||||||
| +1.17% | ||||||
| +5.39% | ||||||
| +18.31% | ||||||
| Average | +44.09% | |||||
| Weighted average by Cap. | +20.88% |
Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.985USD
Average target price
11.00USD
Spread / Average Target
+268.51%
High Price Target
11.00USD
Spread / Highest target
+268.51%
Low Price Target
11.00USD
Spread / Lowest Target
+268.51%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| HC Wainwright |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.985USD
Average target price
11.00USD
Spread / Average Target
+268.51%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GALT Stock
- Consensus Galectin Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
















